Cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group 1: For one of the lesions, glucantime (vial 1gr/5cc) will be injected intralesional with insulin syringe. The interval between the injections will be one week until
Treatment - Drugs
Treatment - Devices
Intervention group 1: For one of the lesions, glucantime (vial 1gr/5cc) will be injected intralesional with insulin syringe. The interval between the injections will be one week until the lesion will
Intervention group 2: The other lesion will be treated with PDL laser(N light, model A00-0159) with the setting of 7j/cm2 fluence, and 5cm spot size. Laser therapy will be continued with 2 weeks inter
Sponsors
Dr Radmanesh clinic
Eligibility
Sex/Gender
All
Age
5 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age between 5-55 years; having at least 2 leishmania lesion on the everywhere of body skin with positive direct smear for leishman body. Exclusion criteria: Pregnancy; lactation; using any other treatments before the beginning of the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Induration index. Timepoint: Before the begionning of the study, Every 2 weeks for 10 weeks. Method of measurement: Physical examination by dermatologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post inflammatory hyperpigmantation. Timepoint: Every 2 weeks for 10 weeks. Method of measurement: Physical examination by dermatologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Omidian
Ahvaz Jondishapur University of Medical Sciences
Outcome results
None listed